Previous My PrEP Experience Posts

Thursday, September 5, 2013

The New Revolution: Bob Grant Talks PrEP in Special Issue of Positively Aware

by Robert Grant, MD, MPH (via Positively Aware's recent "Let's Talk about PrEP" issue)  
"PrEP is a proven concept. A single tablet that contains two medications originally approved to treat HIV/AIDS, tenofovir and emtricitabine (brand name “Truvada” in the United States), was approved to prevent sexual transmission of HIV by the Food and Drug Administration (FDA) in July 2012. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have issued guidelines for the use of PrEP. The medication is already available in generic form to people living in the poorest countries of the world."
 

Antiretroviral therapy has revolutionized care for people living with HIV/AIDS by prolonging life and restoring health, preventing transmission to uninfected partners, and preventing tuberculosis disease. These same medications can be taken by HIV-negative people with the goal of staying free of HIV. The combination of highly active antiretroviral interventions for both HIV prevention and treatment has led to unprecedented optimism about the prospect of ending AIDS.

The preventive use of anti-HIV medicines by HIV-negative people is called post-exposure prophylaxis (or PEP) if the medicines are started after sex or a needle stick that could lead to HIV transmission. Pre-exposure prophylaxis, or PrEP, is when medicines are used before and after possible exposures to HIV infection.

Read the rest here.


No comments:

Post a Comment